Content The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy 8 June 2026
Content From Crisis to Capability: What Will It Actually Take to Build a Resilient Global Vaccine Supply Chain? 4 June 2026
Podcast How Trump’s Most-Favored-Nation Policy Is Forcing Europe’s Pharma Industry to Reconsider Its Pricing Strategy 9 March 2026
Podcast U.S. Vaccine Policy Shifts Create a “Chilling” Effect on Global Manufacturing and Innovation 23 February 2026
Manufacturing News Cytiva Global Biopharma Index Finds Supply Chain Resilience Improving While Talent Pool Declines 7 October 2025
